Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00725322 · ClinicalTrials.gov registry record · NA

Subcutaneous Botulinum Toxin for Cutaneous Allodynia

A NA study of Pain, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT00725322: Completed NA study of Pain, sponsored by Stanford University.

NCT00725322 is a NA study of Pain that has completed, run by Stanford University. The registered enrollment target is 84 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00725322, a NA study of Pain, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

Superficial injection of Botulinum toxin has been advocated for cosmetic purposes but has also been reported to be helpful for some pain conditions. The investigators have observed prolonged profound analgesia following subcutaneous superficial injection of Botulinum Toxin Type A (BTA) in patients with certain types of neuropathic pain. The investigators propose to study if addition of BTA extends pain relief compared to placebo when injected subcutaneously into areas of cutaneous allodynia (the property that a normally non-noxious stimulus is perceived as painful).

Conditions Studied

Pain

Interventions

  • DRUG Botulinum Toxin A
  • DRUG Placebo - Saline

Study Locations (1)

California

  • Stanford University School of Medicine - Stanford

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2007-12
Est. Completion 2013-03
Phase NA

Sponsor

Stanford University

1,744 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00725322

The ClinicalTrials.gov registry entry for NCT00725322 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (72% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Botulinum Toxin A is the first listed.

NCT00725322 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00725322 about?

NCT00725322 is a clinical study titled "Subcutaneous Botulinum Toxin for Cutaneous Allodynia". Superficial injection of Botulinum toxin has been advocated for cosmetic purposes but has also been reported to be helpful for some pain conditions. The investigators have observed prolonged profound analgesia following subcutaneous superficial injection of Botulinum Toxin Type A (BTA) in patients w...

What is the current status of trial NCT00725322?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2007-12. Estimated completion is 2013-03.

What conditions does trial NCT00725322 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT00725322?

The interventions under investigation include: Botulinum Toxin A (DRUG), Placebo - Saline (DRUG).

Who is sponsoring clinical trial NCT00725322?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00725322 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.